This News May Mean Billions for Regeneron

Investors have given coronavirus vaccine stocks a lot of attention. But treatment makers, such as Regeneron Pharmaceuticals (NASDAQ: REGN), also make promising investments. In this Motley Fool Live video recorded on June 22, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss recent news from Regeneron that could equal more orders for the company's COVID-19 treatment -- and its stock performance down the road.

Continue reading

Source Fool.com